Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Otter Tail
OTTR
$3.9B
| $110K | ﹤0.01% |
1,795
-269
| -13% | -$19.4K |
|
|
SRDX
3352
DELISTED
Surmodics
SRDX
| $110K | ﹤0.01% |
3,614
-4,709
| -57% | -$162K |
|
3353
Alico
ALCO
$283M
| $109K | ﹤0.01% |
3,835
-2,212
| -37% | -$74.7K |
|
3354
Vanguard FTSE Pacific ETF
VPL
$8.36B
| $109K | ﹤0.01% |
1,891
-17,735
| -90% | -$1.13M |
|
|
TBRG
3355
DELISTED
TruBridge
TBRG
| $109K | ﹤0.01% |
3,904
-5,963
| -60% | -$184K |
|
3356
Mercer International
MERC
$47.5M
| $108K | ﹤0.01% |
8,749
-1,807
| -17% | -$26.7K |
|
3357
Invesco Semiconductors ETF
PSI
$2.47B
| $108K | ﹤0.01% |
3,591
-3
| -0.1% | -$104 |
|
|
ENDP
3358
DELISTED
Endo International plc
ENDP
| $108K | ﹤0.01% |
1,124,326
+1,081,240
| +2,509% | +$500K |
|
3359
Kinetik
KNTK
$3.58B
| $107K | ﹤0.01% |
3,311
-904
| -21% | -$33.3K |
|
|
PUCK
3360
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
| $107K | ﹤0.01% |
+10,850
| New | +$107K |
|
3361
eGain
EGAN
$200M
| $106K | ﹤0.01% |
14,369
+4,641
| +48% | +$41.7K |
|
3362
Noodles & Co
NDLS
$106M
| $106K | ﹤0.01% |
2,822
-21
| -0.7% | -$834 |
|
3363
Polestar Automotive Holding UK
PSNY
$2.12B
| $106K | ﹤0.01% |
700
| – | – |
|
3364
ARS Pharmaceuticals
SPRY
$528M
| $106K | ﹤0.01% |
19,985
-912
| -4% | -$4.49K |
|
|
STKL
3365
DELISTED
SunOpta
STKL
| $106K | ﹤0.01% |
11,596
-760
| -6% | -$7.21K |
|
|
VTYX
3366
DELISTED
Ventyx Biosciences
VTYX
| $106K | ﹤0.01% |
3,048
-275,335
| -99% | -$6.1M |
|
|
MAXR
3367
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $106K | ﹤0.01% |
5,653
+909
| +19% | +$22.3K |
|
|
IPVI
3368
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
| $106K | ﹤0.01% |
+10,723
| New | +$105K |
|
3369
OraSure Technologies
OSUR
$287M
| $105K | ﹤0.01% |
27,567
+4,974
| +22% | +$18K |
|
3370
Vitamin Cottage Natural Grocers
NGVC
$750M
| $104K | ﹤0.01% |
9,637
-72
| -0.7% | -$1.07K |
|
|
CSW
3371
CSW Industrials
CSW
$5.69B
| $103K | ﹤0.01% |
858
+105
| +14% | +$12.8K |
|
3372
N-able
NABL
$981M
| $103K | ﹤0.01% |
11,083
-3,798
| -26% | -$37K |
|
3373
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.1B
| $103K | ﹤0.01% |
530
| – | – |
|
3374
PUT
Ginkgo Bioworks
DNA
$612M
| $102K | ﹤0.01% |
810
| – | – |
|
|
DOO
3375
Bombardier Recreational Products
DOO
$4.73B
| $102K | ﹤0.01% |
1,664
+481
| +41% | +$34K |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 533 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.